Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stergios A Polyzos

Showing results (131-140 of 431) with videos related to

Pageof 44
Sort By:
Medical Hypotheses|January 19, 2010
Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coinStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Diabetes Care|June 23, 2012
Comment on: Jeon et al. Helicobacter pylori Infection Is Associated With an Increased Rate of Diabetes. Diabetes Care 2012;35:520-525Stergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Expert Review of Clinical Pharmacology|October 21, 2023
The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver diseaseChara Tsiampali, Paraskevi Papaioannidou, Antonis Goulas, et al.
Hormones (Athens, Greece)|November 12, 2023
Nonalcoholic fatty liver disease test: an external validation cohortStergios A Polyzos, Apostolis Papaefthymiou, Michael Doulberis, et al.
Hormones (Athens, Greece)|June 15, 2026
Non-invasive imaging diagnostic techniques in metabolic dysfunction-associated steatotic liver disease: a roadmap for cliniciansIoannis Lamprinakos, Myrsini Orfanidou, Vasileios Rafailidis, et al.
Diabetes, Obesity & Metabolism|January 20, 2026
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction-associated steatohepatitis?Stergios A Polyzos, Jannis Kountouras, Leonidas H Duntas, et al.
Metabolism Open|May 7, 2025
The potential role of adipokines and hepatokines in age-related ocular diseasesStavroula Almpanidou, Ilias D Vachliotis, Antonis Goulas, et al.
Metabolism: Clinical and Experimental|May 14, 2013
Irisin: a renaissance in metabolism?Stergios A Polyzos, Jannis Kountouras, Kelsey Shields, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|March 1, 2023
Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implicationsStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Expert Opinion on Investigational Drugs|October 16, 2014
Investigational parathyroid hormone receptor analogs for the treatment of osteoporosisStergios A Polyzos, Polyzois Makras, Zoe Efstathiadou, et al.
Pageof 44

Showing results (131-140 of 431) with videos related to

Sort By:
Pageof 44
Medical Hypotheses|January 19, 2010
Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coinStergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Diabetes Care|June 23, 2012
Comment on: Jeon et al. Helicobacter pylori Infection Is Associated With an Increased Rate of Diabetes. Diabetes Care 2012;35:520-525Stergios A Polyzos, Jannis Kountouras, Christos Zavos, et al.
Expert Review of Clinical Pharmacology|October 21, 2023
The role of glucagon-like peptide-1 receptor agonists in nonalcoholic fatty liver diseaseChara Tsiampali, Paraskevi Papaioannidou, Antonis Goulas, et al.
Hormones (Athens, Greece)|November 12, 2023
Nonalcoholic fatty liver disease test: an external validation cohortStergios A Polyzos, Apostolis Papaefthymiou, Michael Doulberis, et al.
Hormones (Athens, Greece)|June 15, 2026
Non-invasive imaging diagnostic techniques in metabolic dysfunction-associated steatotic liver disease: a roadmap for cliniciansIoannis Lamprinakos, Myrsini Orfanidou, Vasileios Rafailidis, et al.
Diabetes, Obesity & Metabolism|January 20, 2026
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction-associated steatohepatitis?Stergios A Polyzos, Jannis Kountouras, Leonidas H Duntas, et al.
Metabolism Open|May 7, 2025
The potential role of adipokines and hepatokines in age-related ocular diseasesStavroula Almpanidou, Ilias D Vachliotis, Antonis Goulas, et al.
Metabolism: Clinical and Experimental|May 14, 2013
Irisin: a renaissance in metabolism?Stergios A Polyzos, Jannis Kountouras, Kelsey Shields, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|March 1, 2023
Wnt/beta-catenin signaling inhibitors and nonalcoholic fatty liver disease: Potential therapeutic implicationsStergios A Polyzos, Jannis Kountouras, Athanasios D Anastasilakis, et al.
Expert Opinion on Investigational Drugs|October 16, 2014
Investigational parathyroid hormone receptor analogs for the treatment of osteoporosisStergios A Polyzos, Polyzois Makras, Zoe Efstathiadou, et al.
Pageof 44